| Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications: systematic review and meta-analysis SM Grandi, KB Filion, S Yoon, HT Ayele, CM Doyle, JA Hutcheon, ... Circulation 139 (8), 1069-1079, 2019 | 447 | 2019 |
| National HIV testing and diagnosis coverage in sub-Saharan Africa: a new modeling tool for estimating the ‘first 90’from program and survey data M Maheu-Giroux, K Marsh, CM Doyle, A Godin, CL Delaunay, LF Johnson, ... Aids 33, S255-S269, 2019 | 55 | 2019 |
| Comparative effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis of observational studies A Douros, M Durand, CM Doyle, S Yoon, P Reynier, KB Filion Drug safety 42, 1135-1148, 2019 | 34 | 2019 |
| Combination HIV prevention strategies among Montreal gay, bisexual, and other men who have sex with men in the PrEP era: a latent class analysis CM Doyle, M Maheu-Giroux, G Lambert, S Mishra, H Apelian, ... AIDS and Behavior 25, 269-283, 2021 | 29 | 2021 |
| Data variability across Canadian administrative health databases: differences in content, coding, and completeness CM Doyle, LM Lix, BR Hemmelgarn, JM Paterson, C Renoux Pharmacoepidemiology and Drug Safety 29, 68-77, 2020 | 28 | 2020 |
| Lanièce Delaunay C, Johnson LF, et al. National HIV testing and diagnosis coverage in sub-Saharan Africa: a new modeling tool for estimating the ‘first 90’from program and … M Maheu-Giroux, K Marsh, CM Doyle, A Godin Aids 33 (Suppl 3), S255-69, 2019 | 25 | 2019 |
| Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research MH Secrest, RW Platt, CR Dormuth, D Chateau, L Targownik, R Nie, ... Pharmacoepidemiology and drug safety 29, 26-34, 2020 | 18 | 2020 |
| Past dynamics of HIV transmission among men who have sex with men in Montréal, Canada: a mathematical modeling study RM Milwid, Y Xia, CM Doyle, J Cox, G Lambert, R Thomas, S Mishra, ... BMC infectious diseases 22 (1), 233, 2022 | 11 | 2022 |
| Population‐level impact of expanding PrEP coverage by offering long‐acting injectable PrEP to MSM in three high‐resource settings: a model comparison analysis SE Stansfield, J Heitner, KM Mitchell, CM Doyle, RM Milwid, M Moore, ... Journal of the International AIDS Society 26, e26109, 2023 | 5 | 2023 |
| Lanièce Delaunay, C M Maheu-Giroux, K Marsh, CM Doyle, A Godin Johnson, LF,... Hankins, CA (2019, December 15). National HIV testing and …, 2019 | 5 | 2019 |
| Measuring progress towards reaching zero new HIV acquisitions among key populations in Québec (Canada) using routine surveillance data: a mathematical modelling study CM Doyle, J Cox, RM Milwid, R Bitera, CL Delaunay, M Alary, G Lambert, ... African Journal of Reproduction and Gynaecological Endoscopy 25 (9), e25994, 2022 | 3 | 2022 |
| Guidelines on long-acting injectable cabotegravir for HIV prevention: web annex D: projected population impact of expanding PrEP coverage by offering long-acting injectable … S Stansfield, J Heitner, K Mitchell, CM Doyle, RM Milwid, M Maheu-Giroux, ... World Health Organization, 2022 | 3 | 2022 |
| Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada … CL Delaunay, MB Klein, A Godin, J Cox, N Kronfli, B Lebouché, C Doyle, ... International Journal of Drug Policy 116, 104026, 2023 | 2 | 2023 |
| Impact of interventions on mpox transmission during the 2022 outbreak in Canada: a mathematical modeling study of three different cities F Xiu, C Doyle, JLF Anato, J Knight, L Wang, J Cox, D Grace, TA Hart, ... medRxiv, 2024.06. 20.24309262, 2024 | | 2024 |
| Exploring the dynamics of the 2022 mpox outbreak in Canada RM Milwid, M Li, A Fazil, M Maheu‐Giroux, CM Doyle, Y Xia, J Cox, ... Journal of Medical Virology 95 (12), e29256, 2023 | | 2023 |
| Population‐level effectiveness of pre‐exposure prophylaxis for HIV prevention among men who have sex with men in Montréal (Canada): a modelling study of surveillance and survey … CM Doyle, RM Milwid, J Cox, Y Xia, G Lambert, C Tremblay, J Otis, ... Journal of the International AIDS Society 26 (12), e26194, 2023 | | 2023 |
| HIV elimination in Québec: tracking progress and evaluating HIV prevention interventions among key populations C Doyle McGill University, 2023 | | 2023 |
| PROJECTED POPULATION IMPACT OF EXPANDING PREP COVERAGE BY OFFERING LONG-ACTING INJECTABLE PREP IN DIFFERENT SETTINGS: MODEL COMPARISON ANALYSIS S Stansfield, J Heitner, K Mitchell, CM Doyle, RM Milwid, M Maheu-Giroux, ... Guidelines on Long-Acting Injectable Cabotegravir for HIV Prevention [Internet], 2022 | | 2022 |
| National HIV testing and diagnosis coverage in sub-Saharan Africa: a new modeling tool for estimating the'first 90'from program and survey data MM Giroux, K Marsh, CM Doyle, A Godin, CL Delaunay, LF Johnson, ... AIDS (Lond.), 225-269, 2019 | | 2019 |
| Data Variability Across Canadian Administrative Health Databases: Differences in Content, Coding, and Completeness CM Doyle, LM Lix, BR Hemmelgarn, JM Paterson, C Renoux PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 26, 558-558, 2017 | | 2017 |
